Business ❯ Healthcare ❯ Pharmaceuticals

Drug Approval

Wegovy New Drug Application Market Withdrawal Cardiovascular Benefits Palsonify Semaglutide Injection Cobenfy Everolimus Tablets Regulatory Compliance Eli Lilly Weight Loss Medications FDA Approval

FDA Approves Novo Nordisk’s Wegovy Pill, First Oral GLP-1

Out-of-pocket buyers will have access through TrumpRx at the same $149 monthly price.

Savara Investors Pressed to Meet Class-Action Deadlines Over Alleged MOLBREEVI BLA Deficiencies

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus